HRA Approval

 

What is HRA Approval?

HRA Approval is the new approval that will be required for research to commence in the NHS in England. It is a new process that comprises a review by a Research Ethics Committee as well as an assessment of regulatory compliance and related matters undertaken by dedicated HRA staff. Although HRA Approval will include a study-wide review in line with the UK-wide agreed standards, the assessment will go beyond this to include new standards and assurances for example, assessment will include the coordination of clinical support assurances for pharmacy and radiation.

When HRA Approval is fully rolled out, it will remove the need for NHS permission to be issued by each participating organisation and will replace the local R&D approval process. HRA Approval will support and complement local processes relating to assessing, arranging and confirming local capacity and capability to undertake the study. When HRA Approval is in place and local capacity and capability confirmed, sites will be able to confirm with the sponsor their readiness to recruit and the study will start at the site.

Back to the top

What difference will it make to health research?

The new system will simplify the approvals process for research, making it easier for research studies to be set up. The elimination of duplicate application routes means that the answers to research questions about how to improve patient care or about new treatments will be answered quicker. Patients will benefit from research funding being dedicated to delivery of research rather than being wasted in navigating complex systems. By removing duplication of reviews of research by NHS support teams, the NHS will be freed up to focus on delivering research.

Back to the top

When will it happen?

HRA has an ambition to implement HRA Approval by December 2015. Implementation will be in a controlled roll out by study type.

HRA Approval will apply to all research studies in England involving the NHS. The phased roll out will involve staff responsible for implementing and supporting the changes inside and outside the HRA, so studies not in the early phase of roll out can still expect to see early benefits to set up times as the HRA Approval begins to bring improvement and efficiency across current systems.

Back to the top

What’s new?

Back to the top

Progress so far

  • After confirmation of funding for the programme at the end of March 2014, HRA began a recruitment process to establish a programme team.
  • The standards associated guidance for all parts of the assessment are well underway – but there is more work to do.
  • The development of the necessary standard operating procedures (SOPs) that HRA staff will use has begun. The HRA is working with several sponsors to identify studies which we can use as a dry run in order to test and refine our SOP
  • The pharmacy and medical exposure technical assurance elements have begun their controlled roll out
  • We have begun to recruit the operational staff for HRA Approval. A training programme for all new staff will be put in place.
  • HRA Approval will be implemented in a controlled, phased roll out approach by study type. These will be announced as the time gets nearer.

Back to the top

Questions and Answers

The Q&As are constantly evolving, and we welcome questions from the research community or public about HRA Approval.

The current version of our Q&As have been segmented for ease of use.

This is to our current document  please contact us if you have any questions. hra.approvalprogramme@nhs.net

Back to the top

Useful Links & Documents

A range of papers, templates and presentations have been created as HRA Approval has been developed and is rolled out.  Listed below are links to some of the key documents and a brief explanation of their purpose.

If you wish to subscribe to HRA communications, please email hra.comms@nhs.net

To keep up to date with the latest developments on the HRA Approval, please follow us via

@HRA_Latest – we will tweet every update to the HRA Approval pages.

Back to the top